Attenuation of high-fat diet-induced rat liver oxidative stress and steatosis by combined hydroxytyrosol-(HT-) eicosapentaenoic acid supplementation mainly relies on HT

Oxidative Medicine and Cellular Longevity

Volumn 2018, Issue , 2018, Pages

  Echeverría, Francisca ^a   Valenzuela, Rodrigo ^a   Bustamante, Andrés ^a   Álvarez, Daniela ^a   Ortiz, Macarena ^b   Soto Alarcon, Sandra A ^a   Muñoz, Patricio ^a   Corbari, Alicia ^a   Videla, Luis A ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD CATÓLICA DEL MAULE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; CARBOHYDRATES; DISEASE CONTROL; MAMMALS; PLANTS (BOTANY); PROTEINS; RECOVERY; UNSATURATED FATTY ACIDS;

ANTIOXIDANT ACTION; ANTIOXIDANT POTENTIAL; EICOSAPENTAENOIC ACID; HEPATIC STEATOSIS; LIPID METABOLISMS; LIPID PEROXIDATION; NON-ALCOHOLIC FATTY LIVER DISEASE; PROTEIN OXIDATION;

OXIDATIVE STRESS;

DNA; ELAVIDA; GLUTATHIONE; HYDROXYTYROSOL; ICOSAPENTAENOIC ACID; MESSENGER RNA; TRANSCRIPTION FACTOR NRF2; 3,4-DIHYDROXYPHENYLETHANOL; ANTIOXIDANT; PHENETHYL ALCOHOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT GAIN; CALORIC INTAKE; COMBINATION DRUG THERAPY; CONTROLLED STUDY; DRUG DNA BINDING; DRUG SCREENING; ENERGY CONSUMPTION; FAT CONTENT; HIGH-FAT DIET-INDUCED STEATOHEPATITIS; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DIET THERAPY; DRUG EFFECT; LIPID DIET; LIPID METABOLISM; LIVER; METABOLISM; NONALCOHOLIC FATTY LIVER; PHYSIOLOGY; RAT;

ACIDS; ANTIOXIDANTS; CARBOHYDRATES; EPA; MAMMALS; PROTEINS; RECOVERY; STRESSES;

ANIMALS; ANTIOXIDANTS; DIET, HIGH-FAT; EICOSAPENTAENOIC ACID; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PHENYLETHYL ALCOHOL; RATS;

EID: 85055178712     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2018/5109503     Document Type: Article

References (49)

1. H. Sies, "Oxidative stress: a concept in redox biology and medicine," Redox Biology, vol. 4, pp. 180-183, 2015.
2. L. A. Videla, "Hormetic responses of thyroid hormone calorigenesis in the liver: association with oxidative stress," IUBMB Life, vol. 62, no. 6, pp. 460-466, 2010.
3. A. K. Singal, S. C. Jampana, and S. A. Weinman, "Antioxidants as therapeutic agents for liver disease," Liver International, vol. 31, no. 10, pp. 1432-1448, 2011.
4. A. P. Rolo, J. S. Teodoro, and C. M. Palmeira, "Role of oxidative stress in the pathogenesis of non-alcoholic steatohepatitis," Free Radical Biology & Medicine, vol. 52, no. 1, pp. 59-69, 2012.
5. L. A. Videla, R. Rodrigo, M. Orellana et al., "Oxidative stressrelated parameters in the liver of nonalcoholic fatty liver disease patients," Clinical Science, vol. 106, no. 3, pp. 261-268, 2004.
6. S. Seki, T. Kitada, and H. Sakaguchi, "Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases," Hepatology Research, vol. 33, no. 2, pp. 132-134, 2005.
7. Z. Yesilova, H. Yaman, C. Oktenli et al., "Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease," American Journal of Gastroenterology, vol. 100, no. 4, pp. 850-855, 2005.
8. R. Valenzuela, A. Espinosa, D. González-Mañán et al., "N-3 long-chain polyunsaturated fatty acid supplementation significantly reduces liver oxidative stress in high fat induced steatosis," PLoS One, vol. 7, no. 10, article e46400, 2012.
9. R. Valenzuela, C. Barrera, A. Espinosa, P. Llanos, P. Orellana, and L. A. Videla, "Reduction in the desaturation capacity of the liver in mice subjected to high fat diet: relation to LCPUFA depletion in liver and extrahepatic tissues," Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 98, pp. 7-14, 2015.
10. G. Tapia, R. Valenzuela, A. Espinosa et al., "N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation," Molecular Nutrition & Food Research, vol. 58, no. 6, pp. 1333-1341, 2014.
11. A. R. Soltis, N. J. Kennedy, X. Xin et al., "Hepatic dysfunction caused by consumption of a high-fat diet," Cell Reports, vol. 21, no. 11, pp. 3317-3328, 2017.
12. J. Willebrords, I. V. A. Pereira, M. Maes et al., "Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research," Progress in Lipid Research, vol. 59, pp. 106-125, 2015.
13. J. K. C. Lau, X. Zhang, and J. Yu, "Animal models of nonalcoholic fatty liver disease: current perspectives and recent advances," The Journal of Pathology, vol. 241, no. 1, pp. 36-44, 2017.
14. Y. Rotman and A. J. Sanyal, "Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease," Gut, vol. 66, no. 1, pp. 180-190, 2016.
15. B. C. T. Field, O. B. Chaudhri, and S. R. Bloom, "Obesity treatment: novel peripheral targets," British Journal of Clinical Pharmacology, vol. 68, no. 6, pp. 830-843, 2009.
16. R. Valenzuela and L. A. Videla, "Crosstalk mechanisms in hepatoprotection: thyroid hormone-docosahexaenoic acid (DHA) and DHA-extra virgin olive oil combined protocols," Pharmacological Research, vol. 132, pp. 168-175, 2018.
17. M. Mardones, R. Valenzuela, P. Romanque et al., "Prevention of liver ischemia reperfusion injury by a combined thyroid hormone and fish oil protocol," The Journal of Nutritional Biochemistry, vol. 23, no. 9, pp. 1113-1120, 2012.
18. M. C. Hernández-Rodas, R. Valenzuela, F. Echeverría et al., "Supplementation with docosahexaenoic acid and extra virgin olive oil prevents liver steatosis induced by a high-fat diet in mice through PPAR-α and Nrf2 upregulation with concomitant SREBP-1c and NF-kB downregulation," Molecular Nutrition & Food Research, vol. 61, no. 12, article 1700479, 2017.
19. C. Tsioufis and C. Thomopoulos, "Combination drug treatment in hypertension," Pharmacological Research, vol. 125, Part B, pp. 266-271, 2017.
20. V. G. Athyros, T. K. Alexandrides, H. Bilianou et al., "The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement," Metabolism, vol. 71, pp. 17-32, 2017.
21. F. Echeverría, M. Ortiz, R. Valenzuela, and L. Videla, "Hydroxytyrosol and cytoprotection: a projection for clinical interventions," International Journal of Molecular Sciences, vol. 18, no. 5, p. 930, 2017.
22. C. Colica, L. di Renzo, D. Trombetta et al., "Antioxidant effects of a hydroxytyrosol-based pharmaceutical formulation on body composition, metabolic state, and gene expression: a randomized double-blinded, placebo-controlled crossover trial," Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 2473495, 14 pages, 2017.
23. R. Valenzuela and L. A. Videla, "The importance of the longchain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity," Food & Function, vol. 2, no. 11, pp. 644-648, 2011.
24. R. Valenzuela, P. Illesca, F. Echeverría et al., "Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation," Food & Function, vol. 8, no. 4, pp. 1526-1537, 2017.
25. E. G. Bligh and W. J. Dyer, "A rapid method of total lipid extraction and purification," Canadian Journal of Biochemistry and Physiology, vol. 37, no. 1, pp. 911-917, 1959.
26. I. Rahman, A. Kode, and S. K. Biswas, "Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method," Nature Protocols, vol. 1, no. 6, pp. 3159-3165, 2006.
27. C. K. Chow, K. Reddy, and A. L. Tappel, "Effect of dietary vitamin E on the activities of the glutathione peroxidase system in rat tissues," The Journal of Nutrition, vol. 103, no. 4, pp. 618-624, 1973.
28. H. Lück, "Catalase," in Methods of Enzymatic Assays, H. U. Bergmeyer, Ed., pp. 885-894, Academic Press, New York, 1965.
29. D. E. Paglia and W. N. Valentine, "Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase," Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158-169, 1967.
30. H. Horn, "Glytathione reductase," in Methods of Enzymatic Assays, H. U. Bergmeyer, Ed., pp. 875-879, Academic Press, New York, 1965.
31. L. Ernster, F. Navazio, H. Löw, P. Siekevitz, L. Ernster, and E. Diczfalusy, "Soluble diaphorase in animal tissues," Acta Chemica Scandinavica, vol. 12, pp. 595-602, 1958.
32. W. H. Habig, M. J. Pabst, and W. B. Jakoby, "Glutathione S-transferases. The first enzymatic step in mercapturic acid formation," Journal of Biological Chemistry, vol. 249, no. 22, pp. 7130-7139, 1974.
33. S. Satomura, Y. Miki, T. Hamanaka, and Y. Sakata, "Kinetic assay of gamma-glutamyltransferase with use of bilirubin oxidase as a coupled enzyme," Clinical Chemistry, vol. 31, no. 8, pp. 1380-1383, 1985.
34. M. A. Rincón-Cervera, R. Valenzuela, M. C. Hernandez-Rodas et al., "Supplementation with antioxidant-rich extra virgin olive oil prevents hepatic oxidative stress and reduction of desaturation capacity in mice fed a high-fat diet: effects on fatty acid composition in liver and extrahepatic tissues," Nutrition, vol. 32, no. 11-12, pp. 1254-1267, 2016.
35. S. Piro, L. Spadaro, M. Russello et al., "Molecular determinants of insulin resistance, cell apoptosis and lipid accumulation in non-alcoholic steatohepatitis," Nutrition, Metabolism & Cardiovascular Diseases, vol. 18, no. 8, pp. 545-552, 2008.
36. J. W. Kaspar, S. K. Niture, and A. K. Jaiswal, "Nrf2:INrf2 (Keap1) signaling in oxidative stress," Free Radical Biology & Medicine, vol. 47, no. 9, pp. 1304-1309, 2009.
37. P. Delerive, K. de Bosscher, S. Besnard et al., "Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1," Journal of Biological Chemistry, vol. 274, no. 45, pp. 32048-32054, 1999.
38. S. Hong, K. Gronert, P. R. Devchand, R. L. Moussignac, and C. N. Serhan, "Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids and anti-inflammation," Journal of Biological Chemistry, vol. 278, no. 17, pp. 14677-14687, 2003.
39. B. de Roos, Y. Mavrommatis, and I. A. Brouwer, "Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease," British Journal of Pharmacology, vol. 158, no. 2, pp. 413-428, 2009.
40. L. Gao, J. Wang, K. R. Sekhar et al., "Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3," Journal of Biological Chemistry, vol. 282, no. 4, pp. 2529-2537, 2007.
41. S. Cicerale, L. J. Lucas, and R. S. J. Keast, "Antimicrobial, antioxidant and anti-inflammatory phenolic activities in extra virgin olive oil," Current Opinion in Biotechnology, vol. 23, no. 2, pp. 129-135, 2012.
42. H. Zrelli, M. Matsuoka, S. Kitazaki et al., "Hydroxytyrosol induces proliferation and cytoprotection against oxidative injury in vascular endothelial cells: role of Nrf2 activation and HO-1 induction," Journal of Agricultural and Food Chemistry, vol. 59, no. 9, pp. 4473-4482, 2011.
43. R. Valenzuela, F. Echeverria, M. Ortiz et al., "Hydroxytyrosol prevents reduction in liver activity of Δ-5 and Δ-6 desaturases, oxidative stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice," Lipids in Health and Disease, vol. 16, no. 1, p. 64, 2017.
44. G. Tapia, D. Silva, N. Romero et al., "Role of dietary α- and γ-tocopherol from Rosa mosqueta oil in the prevention of alterations induced by high-fat diet in a murine model," Nutrition, vol. 53, pp. 1-8, 2018.
45. F. V. Bruschi, M. Tardelli, T. Claudel, and M. Trauner, "PNPLA3 expression and its impact on the liver: current perspectives," Hepatic Medicine, vol. 9, pp. 55-66, 2017.
46. Z. Zheng, C. Zhang, and K. Zhang, "Role of unfolded protein response in lipogenesis," World Journal of Hepatology, vol. 2, no. 6, pp. 203-207, 2010.
47. H. Malhi and R. J. Kaufman, "Endoplasmic reticulum stress in liver disease," Journal of Hepatology, vol. 54, no. 4, pp. 795-809, 2011.
48. C. L. Gentile, M. A. Frye, and M. J. Pagliassotti, "Fatty acids and the endoplasmic reticulum in non-alcoholic fatty liver disease," BioFactors, vol. 37, no. 1, pp. 8-16, 2011.
49. S. Granados-Principal, N. el-azem, R. Pamplona et al., "Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer," Biochemical Pharmacology, vol. 90, no. 1, pp. 25-33, 2014.